This most up-to-date twist while in the Lykos Therapeutics saga threatens a major overhaul of the corporate’s method and route, with Musk ally and billionaire Trader Antonio Gracias appearing to want to just take the organization again toward its nonprofit drug improvement roots and a more Doblinite philosophy.In lots of respects, the for-financi